Trial Profile
Phase I trial of PD-1 combination with CCR5 inhibition for the treatment of metastatic gastric cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2017
Price :
$35
*
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 11 Dec 2017 New trial record